Patent · US Active

Pharmaceutical suspension for oral dosage

US11931455B2 · kind B2 · utility

2Cited by

3References

2Claims

0Family size

Assignee

Liqmeds Worldwide Limited · GB

Inventors

Sandip P. Mehta · Ahmedabad, IN
Manish Umrethia · Ahmedabad, IN
Jayanta Kumar MANDAL · Ahmedabad, IN

Key dates

Filing date	Jul 31, 2023
Grant date	Mar 19, 2024
Priority date	—
Expiry date	Jul 31, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/38
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are pharmaceutical compositions in the form of a suspension for oral delivery. Some embodiments provide a pharmaceutical composition in the form of a suspension for oral delivery comprising an active pharmaceutical ingredient; water; a suspending agent; a buffering agent; and one or more of a wetting agent and a binder/filler. In some embodiments, the active pharmaceutical ingredient is selected from quetiapine, sildenafil, tadalafil, cinacalcet, ticagrelor, mycophenolate, aprepitant, zonisamide, and primidone.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.